Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.65 |
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.59 |
| ▸ | GLP1R | P43220 | 3/20 | 0.59 |
| ▸ | GCGR | P47871 | 1/20 | 0.59 |
| ▸ | GIPR | P48546 | 1/20 | 0.59 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.58 |
| ▸ | PTH1R | Q03431 | 2/20 | 0.57 |
| ▸ | VIPR1 | P32241 | 2/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.55 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.55 |
| ▸ | VIPR2 | P41587 | 2/20 | 0.55 |
| ▸ | CCKBR | P32239 | 1/20 | 0.55 |
| ▸ | ECE1 | P42892 | 1/20 | 0.54 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31211751 | 0.93 | TFPI (0.61) | TFPIIL23RGLP1RGCGRGIPR | |
| Acetic Acid SCHEMBL29533494 | 0.91 | TFPI (0.69) | TFPIKEAP1PTH1RVIPR1OPRM1 | |
| SCHEMBL29387068 | 0.91 | TFPI (0.69) | TFPIKEAP1PTH1RVIPR1OPRM1 | |
| SCHEMBL29366672 | 0.91 | TFPI (0.69) | TFPIKEAP1PTH1RVIPR1OPRM1 | |
| SCHEMBL29405667 | 0.91 | TFPI (0.66) | TFPIKEAP1OPRM1OPRD1OPRK1 | |
| SCHEMBL30842196 | 0.90 | OPRM1 (0.64) | TFPIOPRM1OPRD1OPRK1 | |
| SCHEMBL30863947 | 0.90 | TFPI (0.66) | TFPIOPRM1OPRD1OPRK1 | |
| SCHEMBL30524359 | 0.89 | TFPI (0.61) | TFPIIL23RGLP1RGCGRGIPR | |
| Tyrlysseraspserphetyrglyleumet SCHEMBL30475005 | 0.89 | OPRM1 (0.61) | TFPIIL23ROPRM1OPRD1OPRK1 | |
| SCHEMBL30277897 | 0.89 | TFPI (0.60) | TFPIIL23RGLP1RGCGRGIPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552848-B2 | Hydrochloride salts of C5a receptor agonist peptides | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2026-02-17 | — | — | US | claimed |
| US-20240238414-A1 | ANTI-PARASITIC IMMUNOLOGICAL COMPOSITIONS | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2024-07-18 | — | — | US | claimed |
| US-12552848-B2 | Hydrochloride salts of C5a receptor agonist peptides | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2026-02-17 | — | — | US | disclosed |
| US-20240238414-A1 | ANTI-PARASITIC IMMUNOLOGICAL COMPOSITIONS | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2024-07-18 | — | — | US | disclosed |
| US-11911464-B2 | Anti-parasitic immunological compositions | PROMMUNE, INC. (US) | 2024-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552848-B2 | Hydrochloride salts of C5a receptor agonist peptides | C5AR1, C5AR2, C3AR1 | TFPI 1772/4885IL23R 1055/4885GLP1R 635/4885 |
| US-20240238414-A1 | ANTI-PARASITIC IMMUNOLOGICAL COMPOSITIONS | C3AR1, C5AR1, C5AR2 | TFPI 895/4885IL23R 538/4885GLP1R 1960/4885 |
| US-11911464-B2 | Anti-parasitic immunological compositions | C3AR1, C5AR1, C5AR2 | TFPI 895/4885IL23R 538/4885GLP1R 1960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.